Celladon celladon.net


Public lists: Smart Money VCs (6327)

Celladon is a biotechnology company developing molecular therapies for the treatment of heart failure. The company's products target the key enzyme deficiency in advanced heart failure, SERCA2a, which regulates calcium cycling and contractility in heart muscle cells. Celladon's initial product candidate, MYDICAR, delivers the gene for the SERCA2a enzyme. Celladon also develops small molecule activators of SERCA2a for acute heart failure.

Celladon is a biotechnology company developing molecular therapies for the treatment of heart failure. The company's products target the key enzyme deficiency in advanced heart failure, SERCA2a, which regulates calcium cycling and contractility in he...Show all

Company (IPO / Went public)

Phone: 858-366-4288

Fax:

12760 High Bluff Drive
Suite 240
San Diego, 92130
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Celladon $161.8M Jan 30, 2014
Carbylan Therapeutics $107.8M Nov 22, 2016
Transcept Pharmaceuticals $70.5M Oct 31, 2014
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Celladon Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 14 investors

Competitors

Company Status Description Investors
See all 15 competitors